Drug Profile
Prinaberel
Alternative Names: ERB-041; WAY-202041Latest Information Update: 02 Oct 2021
Price :
$50
*
At a glance
- Originator Wyeth
- Class Anti-inflammatories; Antirheumatics; Benzoxazoles; Small molecules
- Mechanism of Action Selective estrogen receptor beta agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Crohn's disease; Endometriosis; Rheumatoid arthritis
Most Recent Events
- 28 Sep 2020 Wyeth withdraws a clinical trial in Interstitial cystitis in USA, Austria, Germany (NCT00275379)
- 16 Oct 2008 Discontinued - Phase-I for Endometriosis in Japan (PO)
- 16 Oct 2008 Discontinued - Phase-II for Endometriosis in Australia (PO)